Search - tctmd.com

Displaying 1 - 20 of 72

Sort: Relevancy | Date

Presentation TVT 2023

Case Presentation 1: Failed Supra-Annular TAVR and ‘How To Do’ TAV-in-TAV (Sapien in Evolut)

Presenter: Sachin Goel

June 10, 2023

Presentation TVT 2023

Real-World Early Outcomes of Evolut FX Versus PRO+ Transcatheter Aortic Valve Replacement

Presenter: Wah Wah Htun

June 09, 2023

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

Presenter: Amit Vora

June 08, 2023

Presentation TVT 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presenter: Firas Zahr

June 08, 2023

Presentation TVT 2023

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

Presenter: Amit Vora

June 07, 2023

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Presenter: Reda Ibrahim

June 10, 2022

Presentation TVT 2022

Proven Safety through MitraClip G4 and Evolution of TEER

Presenter: Rahul Sharma

June 09, 2022

Presentation TVT 2022

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Presenter: Andrea Scotti

June 09, 2022

Presentation TVT 2022

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Presenter: John K. Forrest

June 08, 2022

Presentation TVT 2022

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

Presenter: Marc Allard-Ratick

June 08, 2022

Presentation TVT 2022

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Presenter: Sreekanth Vemulapalli

June 08, 2022

Presentation TVT 2022

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Presenter: Pedro Nicz

June 08, 2022

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Todd Neale

July 23, 2021

Presentation TVT 2021

PFO Device Evolution: Do We Need to Reduce the Anatomical Footprint?

Presenter: Horst Sievert

July 22, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

Presentation TVT 2021

TEER Device Evolution: Impact on Technical Success and Complications

Presenter: Anita Asgar

July 20, 2021

Advertisement

Case Presentation 1: Failed Supra-Annular TAVR and ‘How To Do’ TAV-in-TAV (Sapien in Evolut)

Real-World Early Outcomes of Evolut FX Versus PRO+ Transcatheter Aortic Valve Replacement

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Proven Safety through MitraClip G4 and Evolution of TEER

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

PFO Device Evolution: Do We Need to Reduce the Anatomical Footprint?

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

TEER Device Evolution: Impact on Technical Success and Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content